Basic Information
RNALocate ID: | RLID-D:11000216 |
RNA Symbol: | hsa-miR-744-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-744-5p |
RNA ID: | miRBase:MIMAT0004945 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Blood|Endothelial cells |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002696 | Cytoplasm | Neural progenitor cells | 21363885 |
RLID:01002697 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002698 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002699 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002700 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11004134 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11004135 | Exosome | Plasma | 23663360 |
RLID:11004136 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11004137 | Exosome | K562 cells | 24460325 |
RLID:11004138 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11004139 | Microvesicle | Plasma | 23077538 |
RLID:11004140 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000721 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-744-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-68635 |
MNDR | hsa-miR-744-5p | Lymphoma | MNDR-E-MI-68636 |
MNDR | hsa-miR-744-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-68637 |
MNDR | hsa-miR-744-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-68638 |
MNDR | hsa-miR-744-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-68639 |
MNDR | hsa-miR-744-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-68640 |
MNDR | hsa-miR-744-5p | Her2-receptor positive breast cancer | MNDR-E-MI-68641 |
MNDR | hsa-miR-744-5p | Breast cancer luminal | MNDR-E-MI-68642 |
MNDR | hsa-miR-744-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-68643 |
MNDR | hsa-miR-744-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-68644 |
MNDR | hsa-miR-744-5p | Gastric cancer | MNDR-E-MI-68645 |
MNDR | hsa-miR-744-5p | Alzheimer disease | MNDR-E-MI-68646 |
MNDR | hsa-miR-744-5p | Bladder cancer | MNDR-E-MI-68647 |
MNDR | hsa-miR-744-5p | Dysautonomia familial | MNDR-E-MI-68648 |
MNDR | hsa-miR-744-5p | Leukemia | MNDR-E-MI-68649 |
MNDR | hsa-miR-744-5p | Cardiovascular disease | MNDR-E-MI-68650 |
MNDR | hsa-miR-744-5p | Carotid stenosis | MNDR-E-MI-68651 |
MNDR | hsa-miR-744-5p | Lung cancer | MNDR-E-MI-68652 |
MNDR | hsa-miR-744-5p | Parkinson disease | MNDR-E-MI-68653 |
MNDR | hsa-miR-744-5p | Basal-like breast cancer | MNDR-E-MI-68654 |
MNDR | hsa-miR-744-5p | Pituitary neoplasms | MNDR-E-MI-68655 |
MNDR | hsa-miR-744-5p | Pancreatic cancer | MNDR-E-MI-68656 |
MNDR | hsa-miR-744-5p | Williams syndrome | MNDR-E-MI-68657 |
MNDR | hsa-miR-744-5p | Rectum adenocarcinoma | MNDR-E-MI-68658 |
MNDR | hsa-miR-744-5p | Colon cancer | MNDR-E-MI-68659 |
MNDR | hsa-miR-744-5p | Colon adenocarcinoma | MNDR-E-MI-68660 |
MNDR | hsa-miR-744-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-68661 |
MNDR | hsa-miR-744-5p | Acromegaly | MNDR-E-MI-68662 |
MNDR | hsa-miR-744-5p | Glioblastoma | MNDR-E-MI-68663 |
MNDR | hsa-miR-744-5p | Glioma | MNDR-E-MI-68664 |
MNDR | hsa-miR-744-5p | Chordoma | MNDR-E-MI-68665 |
MNDR | hsa-miR-744-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-68666 |
MNDR | hsa-miR-744-5p | Osteosarcoma | MNDR-E-MI-68667 |
MNDR | hsa-miR-744-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-68668 |
MNDR | hsa-miR-744-5p | Liver cancer | MNDR-E-MI-68669 |
MNDR | hsa-miR-744-5p | Gastric adenocarcinoma | MNDR-E-MI-68670 |
MNDR | hsa-miR-744-5p | Pituitary adenoma | MNDR-E-MI-68671 |
MNDR | hsa-miR-744-5p | Lung adenocarcinoma | MNDR-E-MI-68672 |
MNDR | hsa-miR-744-5p | Thyroid carcinoma | MNDR-E-MI-68673 |
MNDR | hsa-miR-744-5p | Pancreatic adenocarcinoma | MNDR-E-MI-68674 |
MNDR | hsa-miR-744-5p | Carcinoma renal cell | MNDR-E-MI-68675 |
MNDR | hsa-miR-744-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-68676 |
MNDR | hsa-miR-744-5p | Clear cell renal cell carcinoma | MNDR-E-MI-68677 |
MNDR | hsa-miR-744-5p | Biliary tract cancer | MNDR-E-MI-68678 |
MNDR | hsa-miR-744-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-68679 |
MNDR | hsa-miR-744-5p | Esophageal cancer | MNDR-E-MI-68680 |
MNDR | hsa-miR-744-5p | T acute lymphoblastic leukemia | MNDR-E-MI-68681 |
MNDR | hsa-miR-744-5p | Acute t cell leukemia | MNDR-E-MI-68682 |
MNDR | hsa-miR-744-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-68683 |
MNDR | hsa-miR-744-5p | Fibromyalgia | MNDR-E-MI-68684 |
MNDR | hsa-miR-744-5p | Adenoma | MNDR-E-MI-68685 |
MNDR | hsa-miR-744-5p | Hepatocellular carcinoma | MNDR-E-MI-68686 |
MNDR | hsa-miR-744-5p | Rheumatoid arthritis | MNDR-E-MI-68687 |
MNDR | hsa-miR-744-5p | Barrett's adenocarcinoma | MNDR-E-MI-68688 |
MNDR | hsa-miR-744-5p | Hodgkin lymphoma | MNDR-E-MI-68689 |
MNDR | hsa-miR-744-5p | Neuromyelitis optica | MNDR-E-MI-68690 |
MNDR | hsa-miR-744-5p | Colorectal cancer | MNDR-E-MI-68691 |
MNDR | hsa-miR-744-5p | Nasopharynx carcinoma | MNDR-E-MI-68692 |
MNDR | hsa-miR-744-5p | Multiple myeloma | MNDR-E-MI-68693 |
MNDR | hsa-miR-744-5p | Nasopharyngeal cancer | MNDR-E-MI-68694 |
MNDR | hsa-miR-744-5p | Epstein-barr virus infections | MNDR-E-MI-68695 |
MNDR | hsa-miR-744-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-68696 |
MNDR | hsa-miR-744-5p | Stroke lacunar | MNDR-E-MI-68697 |
MNDR | hsa-miR-744-5p | Barrett's carcinogenesis | MNDR-E-MI-68698 |
MNDR | hsa-miR-744-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-68699 |
MNDR | hsa-miR-744-5p | Tubulovillous adenoma | MNDR-E-MI-68700 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ARHGAP5 | Homo sapiens | RR00122473 |
TOP